- Home
- FVR vs ABEO Comparison
FVR vs ABEO Comparison
Compare FVR & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FVR
- ABEO
- Stock Information
- Founded
- FVR 2016
- ABEO 1974
- Country
- FVR United States
- ABEO United States
- Employees
- FVR N/A
- ABEO N/A
- Industry
- FVR
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- FVR
- ABEO Health Care
- Exchange
- FVR NYSE
- ABEO Nasdaq
- Market Cap
- FVR 227.7M
- ABEO 256.9M
- IPO Year
- FVR 2024
- ABEO 1980
- Fundamental
- Price
- FVR $12.04
- ABEO $5.95
- Analyst Decision
- FVR Hold
- ABEO Strong Buy
- Analyst Count
- FVR 5
- ABEO 6
- Target Price
- FVR $16.80
- ABEO $18.00
- AVG Volume (30 Days)
- FVR 359.1K
- ABEO 1.1M
- Earning Date
- FVR 08-15-2025
- ABEO 08-11-2025
- Dividend Yield
- FVR 7.08%
- ABEO N/A
- EPS Growth
- FVR N/A
- ABEO N/A
- EPS
- FVR N/A
- ABEO N/A
- Revenue
- FVR $60,901,000.00
- ABEO N/A
- Revenue This Year
- FVR $17.29
- ABEO N/A
- Revenue Next Year
- FVR $8.41
- ABEO $322.37
- P/E Ratio
- FVR N/A
- ABEO N/A
- Revenue Growth
- FVR 15.85
- ABEO N/A
- 52 Week Low
- FVR $10.61
- ABEO $3.93
- 52 Week High
- FVR $19.76
- ABEO $7.32
- Technical
- Relative Strength Index (RSI)
- FVR N/A
- ABEO 51.37
- Support Level
- FVR N/A
- ABEO $5.66
- Resistance Level
- FVR N/A
- ABEO $5.99
- Average True Range (ATR)
- FVR 0.00
- ABEO 0.24
- MACD
- FVR 0.00
- ABEO 0.01
- Stochastic Oscillator
- FVR 0.00
- ABEO 74.19
About FVR FRONTVIEW REIT INC
FrontView REIT Inc is an internally managed net-lease REIT that is experienced in acquiring, owning, and managing out parcel properties that are net-leased to a diversified group of tenants. The tenants of the company include service-oriented businesses, such as restaurants, cellular stores, financial institutions, automotive stores and dealers, medical and dental providers, pharmacies, convenience and gas stores, car washes, home improvement stores, grocery stores, professional services as well as general retail tenants.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.